Claude Sonnet 5 自主选定基因疗法并完成小鼠脑部手术
A Claude model autonomously chose a gene therapy and operated on a mouse brain with no human decision-making
研究团队让 Claude Sonnet 5 在癫痫小鼠模型上自主选择基因疗法、脑区和注射坐标,并操控定制手术设备完成注射,全程由持证兽医批准不可逆步骤。该智能体从 19 种候选疗法中选定一种增强抑制性信号通路的方案,依据三篇论文交叉核对并取均值确定注射坐标,术中通过摄像头做了 32 次观察。中途连接中断后,它判断目标位置超出设备运动范围而拒绝继续,事后证明该判断正确,团队最终手动修改代码才得以推进;更强大的 Claude Opus 5.5 和 Opus 5 则拒绝执行该手术。Ocana-Santero 称此前没有智能体自主选择治疗和脑靶点并在活体哺乳动物上实施的先例,小鼠恢复良好,技术报告尚未发布,结果未经同行评审。
推荐理由
AI 评分 66
实验展示了智能体自主选定治疗方案并完成手术,也暴露了安全限制与人类意图冲突时的对齐难题。
主题
正文
Key Points
An AI agent chose a drug, target region, and coordinates for surgery on a mouse model of epilepsy, then performed the procedure. Midway through, it refused to bypass a safety restriction.
The team gave Claude Sonnet 5 a list of 19 possible gene therapies, an epilepsy mouse model in which researchers induce seizures to test treatments, and access to a custom motorized surgical device with cameras. Its only instruction was to reduce the mouse's seizures.
The agent selected the drug, brain region, and stereotactic coordinates on its own, according to Gabriel Ocana-Santero, Exin Therapeutics cofounder and CEO and a PhD student at the University of Oxford. He described the procedure in a thread on X .
How the agent picked its therapy and target
The agent first analyzed how seizures arise in this particular model, then proposed a therapy that boosts a specific inhibitory signaling pathway in the brain. It picked a brain structure that the scientific literature identifies as the origin point for this type of seizure.
It rejected a second possible target region with a detailed explanation, arguing that the region's effects were too unreliable and had failed in one study against the exact seizure type it was supposed to treat. The agent derived its injection coordinates from three scientific papers, cross-checked the reference points, and averaged the values. It also set the injection volume, speed, and wait times on its own.
During the procedure, the agent watched the surgical field through a camera and made 32 observations, Ocana-Santero says. It tracked the injection and reported whether it saw bleeding.
Safety guardrails backfired mid-surgery
A licensed veterinarian approved every irreversible step and held a physical emergency stop that would immediately cut power to all motors, while the setup also enforced fixed limits such as a cap on injection volume that the agent was expressly forbidden from bypassing.
But those safeguards turned against the team. After a connection dropped, the agent detected that its calculated target position was outside the device's physical range of motion and refused to continue, even when restarting calibration did not change its assessment and a third attempt was made.
The agent turned out to be right, because manual adjustments during an earlier pause had thrown off the control system. Ocana-Santero could not persuade it to proceed despite the anesthetized animal on the table and ultimately had to fix the code by hand.
The incident illustrates the AI alignment problem , or how to make AI agents reliably follow human intent. "Frustrating experience but also revealing how much we can come to depend on these models and what happens when they just say 'no' in the middle of a time-sensitive procedure," Ocana-Santero wrote.
Model choice also reflected the alignment challenge, since Sonnet 5 was the only model willing to carry out the live procedure from start to finish. The more capable Claude Opus 5.5 and Opus 5 both refused, with Opus 5 saying it could not guarantee completion and that stopping with a needle in an anesthetized animal's brain would be worse than not starting at all.
First time an AI agent has treated a living animal on its own
Although autonomous surgical robots already exist and are mechanically more precise than his lab device, Ocana-Santero notes that in previous cases a human always chose the surgery while the robot only carried it out. Here, the agent both chose the treatment and brain target and then performed the procedure on a living animal.
"I am not aware of an agent previously choosing a treatment and a brain target and then delivering it into a living mammal," Ocana-Santero wrote. He calls the approach "in vivo lab in the loop," in which AI agents are fully connected to experimental capabilities in the lab, something Anthropic is also working on with its "Model Hardware Standard" .
The mouse recovered well, according to Ocana-Santero. A technical report is expected to follow. The results have not been peer-reviewed.
Two recent experiments with the latest large language models showed that they've gained significant capability as control units for robots but that alignment in this role is a problem all its own .